Diploma (LON:DPLM) Given New GBX 5,200 Price Target at Jefferies Financial Group

Diploma (LON:DPLM) had its price objective lifted by Jefferies Financial Group from GBX 4,500 to GBX 5,200 in a report released on Thursday morning, Marketbeat Ratings reports. They currently have a hold rating on the stock.

DPLM has been the topic of several other research reports. JPMorgan Chase & Co. reissued a “neutral” rating and issued a GBX 4,440 target price on shares of Diploma in a report on Wednesday, August 6th. Berenberg Bank reiterated a “buy” rating and issued a GBX 5,750 price target on shares of Diploma in a research note on Tuesday, September 2nd. Finally, Shore Capital restated a “hold” rating and set a GBX 5,100 price objective on shares of Diploma in a research report on Thursday, July 17th. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of GBX 5,238.

Diploma Stock Performance

LON:DPLM opened at GBX 5,540 on Thursday. The stock has a 50-day moving average price of GBX 5,273.59 and a 200 day moving average price of GBX 4,616.20. The stock has a market capitalization of £7.43 billion, a P/E ratio of 4,456.96, a P/E/G ratio of 2.82 and a beta of 0.75. Diploma has a 12-month low of GBX 3,532 and a 12-month high of GBX 5,625. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.